When Lucas, a six-year-old from Belgium, was diagnosed with a rare and aggressive brain tumour known as diffuse intrinsic pontine glioma (DIPG), the prognosis was heartbreaking. French doctor Jacques Grill, at Gustave Roussy Cancer Centre in Paris, recalls the emotional challenge of informing Lucas’s parents about the grim reality their son faced.
Yet, against all odds, Lucas’s story turned from despair to hope, marking a significant milestone in medical history.
Defying the Odds: A World First in Brainstem Glioma Treatment
Now 13, Lucas is the first child globally to have been cured of brainstem glioma, showcasing a monumental achievement in cancer research. “Lucas beat all the odds,” Grill proudly states, underscoring the exceptional nature of Lucas’s recovery. This success story arrives just before International Childhood Cancer Day, casting a new light on pediatric cancer.
Despite the joyful outcome for Lucas, the reality for most children diagnosed with DIPG remains dire. While advances in pediatric oncology have led to an 85% survival rate beyond five years for children diagnosed with cancer, those with DIPG face a much bleak outlook, with most not surviving a year post-diagnosis. A recent study indicates that only 10% of children with DIPG survive two years after their diagnosis.
Radiotherapy has been the only intervention modestly slowing the tumour’s progression, as no medication has yet proven effective against this aggressive cancer. Lucas’s recovery brings immense joy to his family and medical team and inspires the worldwide medical community.
